Bionime Corporation (TPE:4737)
Taiwan
· Delayed Price · Currency is TWD 60.60
-1.10 (-1.78%)
Mar 9, 2026, 1:30 PM CST
Bionime Revenue
Bionime had revenue of 458.50M TWD in the quarter ending September 30, 2025, a decrease of -6.10%. This brings the company's revenue in the last twelve months to 1.91B, down -0.38% year-over-year. In the year 2024, Bionime had annual revenue of 1.93B with 10.15% growth.
Revenue (ttm)
1.91B
Revenue Growth
-0.38%
P/S Ratio
2.13
Revenue / Employee
3.83M
Employees
500
Market Cap
4.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.93B | 178.18M | 10.15% |
| Dec 31, 2023 | 1.76B | -455.02M | -20.58% |
| Dec 31, 2022 | 2.21B | 360.67M | 19.50% |
| Dec 31, 2021 | 1.85B | 181.34M | 10.87% |
| Dec 31, 2020 | 1.67B | -504.34M | -23.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nang Kuang Pharmaceutical | 2.16B |
| Maxigen Biotech | 792.49M |
| SciVision Biotech | 886.62M |
| ICARES Medicus | 1.09B |
| St.Shine Optical | 4.40B |
| Pacific Hospital Supply | 2.41B |
| Formosa Optical Technology | 3.98B |
| Medeon Biodesign | 381.90M |